JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

Home・Aandelen Lijst・Karyopharm Therapeutics Inc

Search

Karyopharm Therapeutics Inc

Gesloten

SectorGezondheidszorg

8.73 5.69

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

8.63

Max

8.79

Belangrijke statistieken
By Trading Economics
Inkomsten	-69M -102M
Verkoop	-10M 34M
EPS	-5.69
Winstmarge	-299.886
Werknemers	228
EBITDA	4.7M -18M

Aanbevelingen
By TipRanks
Aanbevelingen	Strong Buy
12 Maanden Prognose	+89.28% upside

Marktinformatie
By TradingEconomics
Marktkapitalisatie	38M 195M
Vorige openingsprijs	3.04
Vorige sluitingsprijs	8.73

Nieuwssentiment

By Acuity

50%

50%

155 / 347 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

5.9501 / 7.66 Steun & Weerstand

Karyopharm Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

3 mei 2026, 23:47 UTC

Winsten

National Australia Bank Warns of Economic Shock as 1st Half Profit Falls -- Update

3 mei 2026, 22:35 UTC

Winsten

National Australia Bank Holds Dividend Despite 19% 1st Half Profit Drop

3 mei 2026, 23:39 UTC

Marktinformatie

Gold Edge Higher Amid Signs of Resilience -- Market Talk

3 mei 2026, 23:34 UTC

Marktinformatie

Oil Declines Amid Mild Risk-on Sentiment -- Market Talk

3 mei 2026, 23:32 UTC

Winsten

National Australia Bank Warns of Economic Shock as 1H Profit Falls -- Update

3 mei 2026, 23:30 UTC

Marktinformatie

Nickel Industries Result Shows Power of Higher Prices -- Market Talk

3 mei 2026, 23:20 UTC

Marktinformatie

RBA Likely to Hike Rates; Guidance and Board Split Key -- Market Talk

3 mei 2026, 23:16 UTC

Acquisities, Fusies, Overnames

GameStop Is Offering to Buy eBay for $56 Billion, CEO Ryan Cohen Says -- WSJ

3 mei 2026, 22:57 UTC

Acquisities, Fusies, Overnames

GameStop Is Offering to Buy eBay For $56 Billion, CEO Ryan Cohen Says -- WSJ

3 mei 2026, 22:57 UTC

Acquisities, Fusies, Overnames

GameStop Has Roughly 5% Stake in eBay, Cohen Says -- WSJ

3 mei 2026, 22:57 UTC

Acquisities, Fusies, Overnames

GameStop Offering to Buy eBay for $125 a Share, or About $56 Billion, CEO Ryan Cohen Says -- WSJ

3 mei 2026, 22:57 UTC

Acquisities, Fusies, Overnames

GameStop Is Prepared to Run Proxy Fight If eBay Isn't Receptive to a Deal, Cohen Says -- WSJ

3 mei 2026, 22:57 UTC

Acquisities, Fusies, Overnames

GameStop Has Around $20 Billion in Debt Financing Committed From TD Bank, Cohen Says -- WSJ

3 mei 2026, 22:45 UTC

Marktinformatie

Global Equities Roundup: Market Talk

3 mei 2026, 22:45 UTC

Marktinformatie

Low-Cost Miners in Spotlight Amid High Energy Prices -- Market Talk

3 mei 2026, 22:20 UTC

Winsten

National Australia Bank Holds Dividend Despite 19% 1H Profit Drop

3 mei 2026, 22:08 UTC

Winsten

NAB's 1H Included Previously Announced A$1.35B Software Amortization Charge>NAB.AU

3 mei 2026, 22:05 UTC

Winsten

NAB 1H Net Interest Income A$9.16B Vs. A$8.445B>NAB.AU

3 mei 2026, 22:05 UTC

Winsten

NAB 1H Credit Impairment Charge A$706M Vs. A$348M>NAB.AU

3 mei 2026, 22:05 UTC

Winsten

NAB 1H Operating Expenses A$5.02B Vs. A$4.81B>NAB.AU

3 mei 2026, 22:04 UTC

Winsten

NAB 1H Net Interest Margin 1.81%>NAB.AU>NAB.AU

3 mei 2026, 22:03 UTC

Winsten

NAB 1H Cash Return on Equity Ex-Large Notable Items 11.6%>NAB.AU

3 mei 2026, 22:03 UTC

Winsten

NAB 1H Cash Return on Equity 8.5%>NAB.AU

3 mei 2026, 22:02 UTC

Winsten

NAB 1H CET1 Capital Ratio 11.65% Vs. 12.01%>NAB.AU

3 mei 2026, 22:02 UTC

Winsten

NAB 1H Cash Earnings A$2.64B>NAB.AU

3 mei 2026, 22:02 UTC

Winsten

NAB 1H Cash Earnings Ex-Notable Items A$3.59B Vs. A$3.58B>NAB.AU

3 mei 2026, 22:01 UTC

Winsten

National Australia Bank Keeps Dividend at A$0.85 >NAB.AU

3 mei 2026, 22:01 UTC

Winsten

National Australia Bank 1H Rev A$11.16B Vs. A$10.28B >NAB.AU

3 mei 2026, 22:01 UTC

Winsten

National Australia Bank 1H Net A$2.75B Vs. Net A$3.41B >NAB.AU

3 mei 2026, 15:06 UTC

Winsten

Berkshire's Greg Abel Marks His First Annual Meeting as CEO. We'd Give Him a B-Plus. -- Barrons.com

Peer Vergelijking

Prijswijziging

Karyopharm Therapeutics Inc Prognose

Koersdoel

By TipRanks

89.28% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 16.6 USD 89.28%

Hoogste 28 USD

Laagste 8 USD

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor Karyopharm Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

6 ratings

6

Buy

0

Hold

0

Sell

Gebaseerd op 6 analisten die aandelenratings hebben gegeven aan Karyopharm Therapeutics Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

5.9501 / 7.66Steun & Weerstand

Recent bullish events outweigh bearish events.

All events are bearish.

There are no events.

Sentiment

By Acuity

155 / 347 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

JNJ

Johnson and Johnson

227.46

UNH

UnitedHealth Group Inc

369.01

TMO

Thermo Fisher Scientific Inc

469.28

ISRG

Intuitive Surgical Inc

457.59

ABT

Abbott Laboratories

89.51

Live chat